(Reuters) -Drugmaker Bristol Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash. (Reporting by Christy Santhosh in Bengaluru; Editing by Vijay Kishore)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: SPANISH NATIONAL SOCCER SQUAD TRAINING, REMARKS BY COACH LUIS DE LA FUENTE COMPLETE…
FRENCH SOCIALIST PARTY'S FAURE: NO GUARANTEE FROM US THAT WE WON’T VOTE DOWN THE NEXT…
FRANKFURT (Reuters) -BASF has agreed to sell a majority stake in its coatings business to…
BEIJING (Reuters) -China has launched an antitrust investigation into U.S. semiconductor manufacturer Qualcomm over its…
(Adds Trump comment about tariffs against China in paragraph 3, statement from China's commerce ministry…
VIDEO SHOWS: SPANISH NATIONAL SOCCER SQUAD TRAINING, REMARKS BY COACH LUIS DE LA FUENTE COMPLETE…